Skip to main content

Market Access Monitor

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

HAS Methodological guide on the assignment of the HAS label to a good practice recommendation updated

On November 29, 2023, the French National Authority for Health (HAS) published an update of the methodological guide on the assignment of the HAS label to a good practice recommendation developed by a professional organization of July 2023. 

This methodological guide explains all the methodological, scientific, and ethical elements that constitute a specification to be respected so that the HAS can attribute its label to a good practice recommendation developed by a professional organization.

The HAS label is awarded by a decision of the HAS Board after consulting the Recommendations, relevance, pathways, and indicators commission (CRPPI). These recommendations have the same value as the HAS recommendations. They will be published on the HAS website.

Any professional organization can request certification of a good practice recommendation. This request must be submitted to the HAS good practices department: actualisation.recommandations@has-sante.fr via the available request form before any start of the development of the recommendation.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.